Join

Compare · BDX vs SINT

BDX vs SINT

Side-by-side comparison of Becton Dickinson and Company (BDX) and SiNtx Technologies Inc. (SINT): market cap, price performance, sector, and recent activity on the wire.

Summary

  • Both BDX and SINT operate in Medical/Dental Instruments (Health Care), so they compete in similar markets.
  • BDX is the larger of the two at $43.32B, about 4255.2x SINT ($10.2M).
  • Over the past year, BDX is down 25.7% and SINT is up 7.3% - SINT leads by 33.0 points.
  • BDX has been more active in the news (9 items in the past 4 weeks vs 2 for SINT).
  • BDX has more recent analyst coverage (25 ratings vs 1 for SINT).
PerformanceBDX-25.68%SINT+7.32%
2025-04-28+0.00%2026-04-24
MetricBDXSINT
Company
Becton Dickinson and Company
SiNtx Technologies Inc.
Price
$152.11-1.77%
$2.64-6.71%
Market cap
$43.32B
$10.2M
1M return
-3.89%
+1.93%
1Y return
-25.68%
+7.32%
Industry
Medical/Dental Instruments
Medical/Dental Instruments
Exchange
NYSE
NASDAQ
IPO
2014
News (4w)
9
2
Recent ratings
25
1
BDX

Becton Dickinson and Company

Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products worldwide. The company's BD Medical segment offers peripheral intravenous (IV) and advanced peripheral catheters, central lines, acute dialysis catheters, vascular care and preparation products, needle-free IV connectors and extensions sets, closed-system drug transfer devices, hazardous drug detection, hypodermic syringes and needles, anesthesia needles and trays, enteral syringes, sharps disposal systems; infusion pumps, dedicated disposables, IV fluids, medication compounding workflow systems, automated medication dispensing, automated supply management systems, medication inventory optimization and tracking systems; syringes, pen needles, and other products for diabetes care; and prefillable drug delivery systems. Its BD Life Sciences segment provides specimen and blood collection products and systems; automated blood and tuberculosis culturing, molecular testing, microorganism identification and drug susceptibility, and liquid-based cytology systems, as well as rapid diagnostic assays, microbiology laboratory automation products, and plated media products; and fluorescence-activated cell sorters and analyzers, antibodies and kits, reagent systems, and solutions for high-throughput single-cell gene expression analysis, as well as clinical oncology, immunological, and transplantation diagnostic/monitoring reagents and analyzers. The company's BD Interventional segment offers hernia and soft tissue repair, biological and bioresorbable grafts, biosurgery, and other surgical products; surgical infection prevention, surgical and laparoscopic instrumentation products; peripheral intervention products; and urology and critical care products. Becton, Dickinson and Company was founded in 1897 and is based in Franklin Lakes, New Jersey.

SINT

SiNtx Technologies Inc.

Sintx Technologies, Inc., an advanced materials company, researches, develops, manufactures, and commercializes silicon nitride ceramics in the United States, Europe, and South America. It offers ceramic based solutions for various medical, industrial, and antipathogenic applications. The company provides solid and porous silicon nitride; silicon nitrite powder; and silicon nitride coating products. It has a collaboration agreement with Oxford Performance Materials, Inc. to develop a poly-ether-ketone-ketone silicon nitride composite based on OXPEKK SC solution casting technology. The company was formerly known as Amedica Corporation and changed its name to Sintx Technologies, Inc. in October 2018. Sintx Technologies, Inc. was incorporated in 1996 and is headquartered in Salt Lake City, Utah.

Latest BDX

Latest SINT